2N-{3-[4-(4,5-dibromo-1H-2-pyrrolylcarboxamido)butylamino]propyl}-4,5-dibromo-1H-2-pyrrolecarboxamide

ID: ALA439783

Chembl Id: CHEMBL439783

PubChem CID: 10508413

Max Phase: Preclinical

Molecular Formula: C17H21Br4N5O2

Molecular Weight: 647.00

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(NCCCCNCCCNC(=O)c1cc(Br)c(Br)[nH]1)c1cc(Br)c(Br)[nH]1

Standard InChI:  InChI=1S/C17H21Br4N5O2/c18-10-8-12(25-14(10)20)16(27)23-6-2-1-4-22-5-3-7-24-17(28)13-9-11(19)15(21)26-13/h8-9,22,25-26H,1-7H2,(H,23,27)(H,24,28)

Standard InChI Key:  FUQALZZVMROPCY-UHFFFAOYSA-N

Associated Targets(Human)

HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Listeria monocytogenes (2626 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pseudomonas aeruginosa (123386 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Escherichia coli (133304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Serratia liquefaciens (11 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Leishmania infantum (5912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Leishmania amazonensis (3813 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trypanosoma cruzi (99888 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 647.00Molecular Weight (Monoisotopic): 642.8429AlogP: 4.31#Rotatable Bonds: 11
Polar Surface Area: 101.81Molecular Species: BASEHBA: 3HBD: 5
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 5#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.71CX Basic pKa: 10.17CX LogP: 2.54CX LogD: 0.02
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.24Np Likeness Score: 0.02

References

1. Behrens C, Christoffersen MW, Gram L, Nielsen PH.  (1997)  A convenient synthesis of pseudoceratidine and three analogs for biological evaluation,  (3): [10.1016/S0960-894X(96)00622-1]
2. Parra LLL, Bertonha AF, Severo IRM, Aguiar ACC, de Souza GE, Oliva G, Guido RVC, Grazzia N, Costa TR, Miguel DC, Gadelha FR, Ferreira AG, Hajdu E, Romo D, Berlinck RGS..  (2018)  Isolation, Derivative Synthesis, and Structure-Activity Relationships of Antiparasitic Bromopyrrole Alkaloids from the Marine Sponge Tedania brasiliensis.,  81  (1): [PMID:29297684] [10.1021/acs.jnatprod.7b00876]

Source